Abstract:Aims/hypothesis: Hyperglucagonaemia-stimulated hepatic glucose production (HGP) contributes to hyperglycaemia during type 2 diabetes. A better understanding of glucagon action is important to enable efficient therapies to be developed for the treatment of diabetes. Here, we aimed to investigate the role of p38 MAPK family members in glucagon-induced HGP and determine the underlying mechanisms by which p38 MAPK regulates glucagon action. Methods: p38α, β, γ and δ MAPK siRNAs were transfected into primary hepatocytes, followed by measurement of glucagon-induced HGP. Adeno-associated virus serotype 8 carrying p38α MAPK short hairpin RNA (shRNA) was injected into liver-specific Foxo1 knockout, liver-specific Irs1/Irs2 double knockout and Foxo1S273D knockin mice. Foxo1S273A knockin mice were fed a high-fat diet for 10 weeks. Pyruvate tolerance tests, glucose tolerance tests, glucagon tolerance tests and insulin tolerance tests were carried out in mice, liver gene expression profiles were analysed and serum triglyceride, insulin and cholesterol levels were measured. Phosphorylation of forkhead box protein O1 (FOXO1) by p38α MAPK in vitro was analysed by LC-MS. Results: We found that p38α MAPK, but not the other p38 isoforms, stimulates FOXO1-S273 phosphorylation and increases FOXO1 protein stability, promoting HGP in response to glucagon stimulation. In hepatocytes and mouse models, inhibition of p38α MAPK blocked FOXO1-S273 phosphorylation, decreased FOXO1 levels and significantly impaired glucagon- and fasting-induced HGP. However, the effect of p38α MAPK inhibition on HGP was abolished by FOXO1 deficiency or a Foxo1 point mutation at position 273 from serine to aspartic acid (Foxo1S273D) in both hepatocytes and mice. Moreover, an alanine mutation at position 273 (Foxo1S273A) decreased glucose production, improved glucose tolerance and increased insulin sensitivity in diet-induced obese mice. Finally, we found that glucagon activates p38α through exchange protein activated by cAMP 2 (EPAC2) signalling in hepatocytes. Conclusions/interpretation: This study found that p38α MAPK stimulates FOXO1-S273 phosphorylation to mediate the action of glucagon on glucose homeostasis in both health and disease. The glucagon-induced EPAC2-p38α MAPK-pFOXO1-S273 signalling pathway is a potential therapeutic target for the treatment of type 2 diabetes.

Research development of p38 MAPK and the pathogenesis of diabetes

Review on Abnormal Apoptosis and Pathological Changes of Histiocyte Initiated by Diabetes Mellitus

Expression Changes Of Mitogen-Actilvated Protelin Kinase Phosphatase-1 (Mkp-1) In Myocardium Of Streptozotocin-Induced Diabetic Rats

Diabetes mellitus stimulates pancreatic cancer growth and epithelial-mesenchymal transition-mediated metastasis via a p38 MAPK pathway

Inhibition of P38 Mitogen-Activated Protein Kinase Exerts a Hypoglycemic Effect by Improving Β Cell Function Via Inhibition of Β Cell Apoptosis in Db/db Mice.

The p38 MAPK Components and Modulators as Biomarkers and Molecular Targets in Cancer

Relationship Between High Glucose-Induced Hepatic Stellate Cell Activation and the P38mapk Signaling Pathway

p38 MAPK in Glucose Metabolism of Skeletal Muscle: Beneficial or Harmful?

The interplay of p38 MAPK signaling and mitochondrial metabolism, a dynamic target in cancer and pathological contexts

p38 MAPK pathway is involved in high glucose-induced thioredoxin interacting protein induction in mouse mesangial cells.

p38 MAPK signalling cascades and inflammatory disease

Hepatic p38α MAPK controls gluconeogenesis via FOXO1 phosphorylation at S273 during glucagon signalling in mice

p38 and JNK MAPK pathways control the balance of apoptosis and autophagy in response to chemotherapeutic agents.

Functions of P38 Mitogen-Activated Protein Kinase Alpha and Beta in Human Pancreatic Cancer Cells

To Explore the Pathogenesis of Vascular Lesion of Type 2 Diabetes Mellitus Based on the PI3K/Akt Signaling Pathway

The Protective Effect of Beraprost Sodium on Diabetic Nephropathy by Inhibiting Inflammation and P38 Mapk Signaling Pathway in High-Fat Diet/Streptozotocin-Induced Diabetic Rats

Recent Advance on P38 Mitogen-Activated Protein Kinases Inhibitors

The journey of p38 MAP kinase inhibitors: From bench to bedside in treating inflammatory diseases

Impact of P38γ Mitogen-Activated Protein Kinase (MAPK) on MDA-MB-231 Breast Cancer Cells Using Metabolomic Approach

Signal Transduction Pathway in Diabetic Nephropathy 1 . MAPK signaling pathway in DN

A novel function of p38-regulated/activated kinase in endothelial cell migration and tumor angiogenesis